Session Details
[O-05]Oral Session 05 Parkinson's disease 1
Wed. May 21, 2025 3:35 PM - 5:05 PM JST
Wed. May 21, 2025 6:35 AM - 8:05 AM UTC
Wed. May 21, 2025 6:35 AM - 8:05 AM UTC
第07会場(大阪国際会議場12F 特別会議場)
Chairs: Shigeki Arawaka（Department of Internal Medicine IV, Division of Neurology, Osaka Medical and Pharmaceutical University, Japan）, Kensuke Ikenaka（Department of neurology, Osaka University Graduate School of Medicine, Japan）
[O-05-1]Alpha-synuclein RT-QuIC sensitivity is associated with cardiac MIBG abnormality in Lewy body disease
Masanori Kurihara1,2, Katsuya Satoh3, Ryosuke Shimasaki1, Keiko Hatano1, Kensuke Ohse2, Kenichiro Taira1, Ryoko Ihara1, Mana Higashihara1, Yasushi Nishina1, Masashi Kameyama4, Atsushi Iwata1,2 (1.Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology (TMIG), Japan, 2.Integrated Research Initiative for Living Well with Dementia, TMIG, Japan, 3.Department of Health Sciences, Unit of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan, 4.Research Team for Neuroimaging, TMIG, Japan)
[O-05-2]Plasma Proteomic Analysis in Patients and High-Risk Individuals with Parkinson's Disease
Yuki Saito1, Keita Hiraga1, Taiki Fukushima1, Daigo Tamakoshi1, Takashi Uematsu1, Takashi Tsuboi1, Masashi Suzuki1,2, Maki Sato1, Masayuki Yamamoto3, Hideaki Shimizu4, Masakazu Wakai5, Masahisa Katsuno1,6 (1.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 2.Department of Clinical Laboratory, Nagoya University Hospital, Japan, 3.Kumiai Kosei Hospital, Japan, 4.Daido Clinic, Japan, 5.Chutoen General Medical Center, Japan, 6.Department of Clinical Research Education, Nagoya University Graduate School of Medicine, Japan)
[O-05-3]Role of Nurr1-miR-30e-NLRP3 axis in inflammation-mediated neurodegeneration of Parkinson's disease
Tianbai Li, Yiying Hu, Weidong Le (First Affiliated Hospital of Dalian Medical University, China)
[O-05-4]Ten-years accomplishment of Japan Parkinson's Progressive Markers Initiative (J-PPMI)
Yuji Takahashi1, Masahisa Katsuno2, Hideki Mochizuki3, Nobutaka Hattori4, Ryosuke Takahashi5, J-PPMI1,2,3,4,5 (1.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Department of Neurology, Nagoya University Graduate School of Medicine, Japan, 3.Department of Neurology, Graduate School of Medicine, Osaka University, Japan, 4.Department of Neurology, Faculty of Medicine, Juntendo University, Japan, 5.Department of Neurology, Kyoto University Graduate School of Medicine, Japan)
[O-05-5]CSF Mitochondrial DNA Correlates with Body Composition and Energy Metabolism in Parkinson's Disease
Yasuaki Mizutani1, Tsuyoshi Nakai2, Yasuhiro Maeda3, Reiko Ohdake1, Shoko Ri1, Soutarou Noda1, Kazutaka Hayashi1, Kunihisa Katou1, Atsuhiro Higashi1, Toshiki Maeda1, Ryunosuke Nagao1, Seiko Hirota1, Sayuri Shima1, Akihiro Ueda1, Mizuki Ito1, Shinji Ito1, Hirohisa Watanabe1 (1.Department of Neurology, Fujita Health University School of Medicine, Japan, 2.Department of Pharmacotherapeutics and Informatics, Fujita Health University School of Medicine, Japan, 3.Open Facility Center, Fujita Health University, Japan)
[O-05-6]Associations among blood sphingolipids, clinical manifestations and prognosis in Parkinson's disease
Hideki Oizumi1, Takafumi Hasegawa1, Ichiro Kawahata2, Tomoko Totsune1, Yoko Sugimura1, Toru Baba1, Hiroyasu Tanaka1, Toshiaki Takahaxhi1, Masaru Yoshioka1, Tomoki Sekimori3, Kohji Fukunaga3, Atsushi Takeda1,4 (1.Department of Neurology, NHO sendai nishitaga hospital, Japan, 2.Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University Graduate School of Medicine, Japan, 3.Department of CNS Drug Innovation, Tohoku University Graduate School of Pharmaceutical Sciences, Japan, 4.Department of Cognitive and Motor Aging, Tohoku University Graduate School of Medicine, Japan)